Results: 1-20 |
Results: 20

Authors: Dahlof, C
Citation: C. Dahlof, Assessing patient preference in migraine treatment, CEPHALALGIA, 21(8), 2001, pp. 791-795

Authors: Dahlof, C Linde, M
Citation: C. Dahlof et M. Linde, One-year prevalence of migraine in Sweden: a population-based study in adults, CEPHALALGIA, 21(6), 2001, pp. 664-671

Authors: Diener, HC Tfelt-Hansen, P de Beukelaar, F Ferrari, MD Olesen, J Dahlof, C Mathew, N
Citation: Hc. Diener et al., The efficacy and safety of sc Alniditan vs. sc Sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial, CEPHALALGIA, 21(6), 2001, pp. 672-679

Authors: Dahlof, C
Citation: C. Dahlof, Clinical efficacy and tolerability of sumatriptan tablet and suppository in the acute treatment of migraine: a review of data from clinical trials, CEPHALALGIA, 21, 2001, pp. 9-12

Authors: Goadsby,"Lance, J Ferrari, M Dahlof, C Watson, D Mathew, N Diener, HC Goldstein, J Salonen, R Messina, E Rapaport, A O'Sullivan, E",Saxena,Dowson
Citation: J. Goadsby,"lance et al., Imigran: Ten years of improving the lives of migraine patients - Rome, 24 March 2000 - Questions from the audience, CEPHALALGIA, 21, 2001, pp. 39-41

Authors: Dahlof, C Tfelt-Hansen, P Massiou, H Fazekas, A
Citation: C. Dahlof et al., Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine, NEUROLOGY, 57(10), 2001, pp. 1811-1817

Authors: Dahlof, C Goadsby, PJ
Citation: C. Dahlof et Pj. Goadsby, Ergots - Therapy, MG CLIN NEU, 17, 2000, pp. 66-82

Authors: Dahlof, C Lines, C
Citation: C. Dahlof et C. Lines, Rizatriptan - Therapy, MG CLIN NEU, 17, 2000, pp. 162-172

Authors: Tfelt-Hansen, P Block, G Dahlof, C Diener, HC Ferrari, MD Goadsby, PJ Guidetti, V Jones, B Lipton, RB Massiou, H Meinert, C Sandrini, G Steiner, T Winter, PBO
Citation: P. Tfelt-hansen et al., Guidelines for controlled trials of drugs in migraine: second edition, CEPHALALGIA, 20(9), 2000, pp. 765-786

Authors: Linton-Dahlof, P Linde, M Dahlof, C
Citation: P. Linton-dahlof et al., Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study, CEPHALALGIA, 20(7), 2000, pp. 658-662

Authors: Havanka, H Dahlof, C Pop, PHM Diener, HC Winter, P Whitehouse, H Hassani, H
Citation: H. Havanka et al., Efficacy of naratriptan tablets in the acute treatment of migraine: A dose-ranging study, CLIN THER, 22(8), 2000, pp. 970-980

Authors: Tfelt-Hansen, P Saxena, PR Dahlof, C Pascual, J Lainez, M Henry, P Diener, HC Schoenen, J Ferrari, MD Goadsby, PJ
Citation: P. Tfelt-hansen et al., Ergotamine in the acute treatment of migraine - A review and European consensus, BRAIN, 123, 2000, pp. 9-18

Authors: Peikert, A Becker, WJ Ashford, EA Dahlof, C Hassani, H Salonen, RJ
Citation: A. Peikert et al., Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine, EUR J NEUR, 6(1), 1999, pp. 43-49

Authors: Dahlof, C
Citation: C. Dahlof, Almotriptan - A viewpoint, CNS DRUGS, 11(2), 1999, pp. 166-166

Authors: Thulin, T Lehtonen, A Dahlof, C Nilsson-Ehle, P Engqvist, L Lagerstedt, C Berglund, E
Citation: T. Thulin et al., Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients, INT J CL PH, 37(1), 1999, pp. 28-33

Authors: Dahlof, C
Citation: C. Dahlof, Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies, CEPHALALGIA, 19(9), 1999, pp. 769-778

Authors: Dahlof, C
Citation: C. Dahlof, How to assess patient preference of migraine treatments, CEPHALALGIA, 19, 1999, pp. 2-6

Authors: Dahlof, C
Citation: C. Dahlof, Indirect cost of migraine, CEPHALALGIA, 19(1), 1999, pp. 1-1

Authors: Dahlof, C
Citation: C. Dahlof, Safety and tolerability of the novel 5-HT1B/1D agonist rizatriptan in migraineurs, HEADACHE, 39, 1999, pp. S16-S18

Authors: Dahlof, C
Citation: C. Dahlof, The SF-36 and the assessment of HRQoL, CEPHALALGIA, 18(9), 1998, pp. 592-592
Risultati: 1-20 |